KeyBank National Association’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.33M | Sell |
36,763
-1,954
| -5% | -$164K | 0.01% | 378 |
|
|
2026
Q1 | $3.1M | Buy |
38,717
+4,809
| +14% | +$396K | 0.01% | 373 |
|
|
2025
Q4 | $2.89M | Sell |
33,908
-1,807
| -5% | -$148K | 0.01% | 374 |
|
|
2025
Q3 | $2.78M | Sell |
35,715
-457
| -1% | -$35.7K | 0.01% | 381 |
|
|
2025
Q2 | $2.83M | Buy |
36,172
+233
| +0.6% | +$17.4K | 0.01% | 374 |
|
|
2025
Q1 | $2.6M | Sell |
35,939
-6,934
| -16% | -$496K | 0.01% | 387 |
|
|
2024
Q4 | $3.17M | Sell |
42,873
-1,354
| -3% | -$94.8K | 0.01% | 351 |
|
|
2024
Q3 | $2.92M | Sell |
44,227
-2,138
| -5% | -$155K | 0.01% | 362 |
|
|
2024
Q2 | $4.28M | Sell |
46,365
-2,434
| -5% | -$216K | 0.02% | 298 |
|
|
2024
Q1 | $4.66M | Buy |
48,799
+4,820
| +11% | +$405K | 0.02% | 289 |
|
|
2023
Q4 | $3.35M | Sell |
43,979
-1,417
| -3% | -$98.6K | 0.01% | 325 |
|
|
2023
Q3 | $3.15M | Sell |
45,396
-5,667
| -11% | -$455K | 0.02% | 316 |
|
|
2023
Q2 | $4.82M | Buy |
51,063
+4,835
| +10% | +$420K | 0.02% | 272 |
|
|
2023
Q1 | $3.82M | Buy |
46,228
+7,344
| +19% | +$577K | 0.02% | 299 |
|
|
2022
Q4 | $2.9M | Sell |
38,884
-3,825
| -9% | -$295K | 0.01% | 325 |
|
|
2022
Q3 | $3.53M | Sell |
42,709
-1,972
| -4% | -$190K | 0.02% | 290 |
|
|
2022
Q2 | $4.25M | Buy |
44,681
+779
| +2% | +$80.6K | 0.02% | 276 |
|
|
2022
Q1 | $5.17M | Sell |
43,902
-2,271
| -5% | -$255K | 0.02% | 266 |
|
|
2021
Q4 | $5.98M | Buy |
46,173
+1,483
| +3% | +$173K | 0.02% | 264 |
|
|
2021
Q3 | $5.06M | Sell |
44,690
-7,821
| -15% | -$893K | 0.02% | 265 |
|
|
2021
Q2 | $5.44M | Sell |
52,511
-5,756
| -10% | -$543K | 0.02% | 262 |
|
|
2021
Q1 | $4.87M | Sell |
58,267
-1,089
| -2% | -$92.1K | 0.02% | 269 |
|
|
2020
Q4 | $5.42M | Sell |
59,356
-1,029
| -2% | -$85.4K | 0.03% | 255 |
|
|
2020
Q3 | $4.82M | Buy |
60,385
+4,667
| +8% | +$364K | 0.03% | 254 |
|
|
2020
Q2 | $3.85M | Buy |
55,718
+8
| +0% | +$569 | 0.02% | 271 |
|
|
2020
Q1 | $3.5M | Sell |
55,710
-2,073
| -4% | -$149K | 0.02% | 268 |
|
|
2019
Q4 | $4.49M | Buy |
57,783
+1,368
| +2% | +$107K | 0.02% | 275 |
|
|
2019
Q3 | $4.13M | Sell |
56,415
-3,045
| -5% | -$214K | 0.02% | 282 |
|
|
2019
Q2 | $3.66M | Sell |
59,460
-3,813
| -6% | -$231K | 0.02% | 293 |
|
|
2019
Q1 | $4.04M | Buy |
63,273
+2,202
| +4% | +$126K | 0.02% | 279 |
|
|
2018
Q4 | $3.12M | Sell |
61,071
-26,046
| -30% | -$1.32M | 0.02% | 288 |
|
|
2018
Q3 | $5.06M | Buy |
87,117
+8,697
| +11% | +$425K | 0.03% | 259 |
|
|
2018
Q2 | $3.81M | Buy |
78,420
+396
| +0.5% | +$18.5K | 0.02% | 279 |
|
|
2018
Q1 | $3.63M | Buy |
78,024
+1,593
| +2% | +$69.2K | 0.02% | 282 |
|
|
2017
Q4 | $2.87M | Sell |
76,431
-26,400
| -26% | -$969K | 0.02% | 298 |
|
|
2017
Q3 | $3.75M | Buy |
102,831
+8,361
| +9% | +$319K | 0.02% | 277 |
|
|
2017
Q2 | $3.72M | Sell |
94,470
-28,734
| -23% | -$1.05M | 0.02% | 272 |
|
|
2017
Q1 | $3.86M | Buy |
123,204
+55,755
| +83% | +$1.75M | 0.02% | 276 |
|
|
2016
Q4 | $2.11M | Sell |
67,449
-27,144
| -29% | -$879K | 0.01% | 354 |
|
|
2016
Q3 | $3.8M | Buy |
94,593
+22,593
| +31% | +$851K | 0.02% | 281 |
|
|
2016
Q2 | $2.39M | Buy |
72,000
+9,225
| +15% | +$316K | 0.02% | 317 |
|
|
2016
Q1 | $1.85M | Sell |
62,775
-18,978
| -23% | -$524K | 0.01% | 358 |
|
|
2015
Q4 | $2.15M | Sell |
81,753
-13,869
| -15% | -$360K | 0.01% | 344 |
|
|
2015
Q3 | $2.27M | Buy |
95,622
+21,090
| +28% | +$509K | 0.02% | 340 |
|
|
2015
Q2 | $1.77M | Sell |
74,532
-930
| -1% | -$21K | 0.01% | 424 |
|
|
2015
Q1 | $1.79M | Buy |
75,462
+45,858
| +155% | +$1.03M | 0.01% | 434 |
|
|
2014
Q4 | $628K | Buy |
29,604
+216
| +0.7% | +$4.34K | ﹤0.01% | 778 |
|
|
2014
Q3 | $500K | Buy |
29,388
+14,568
| +98% | +$230K | ﹤0.01% | 868 |
|
|
2014
Q2 | $212K | Buy |
+14,820
| New | +$201K | ﹤0.01% | 1195 |
|
|
2014
Q1 | – | Sell |
-18,804
| Closed | -$206K | – | 1272 |
|
|
2013
Q4 | $206K | Buy |
+18,804
| New | +$212K | ﹤0.01% | 1190 |
|
|
2013
Q3 | – | Sell |
-30,732
| Closed | -$344K | – | 1267 |
|
|
2013
Q2 | $344K | Buy |
+30,732
| New | +$364K | ﹤0.01% | 1094 |
|
Other funds holding EW
KeyBank National Association's EW Position: Q2 2026 in Review
KeyBank National Association reduced its Edwards Lifesciences (EW) stake by 5% in Q2 2026, selling an estimated $164K and leaving 36,763 shares worth $3.33M. The position accounts for 0.01% of the portfolio, ranked #378.
KeyBank National Association first reported a position in EW in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.98M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- KeyBank National Association held 36,763 shares of Edwards Lifesciences worth $3.33M as of Q2 2026.
- KeyBank National Association sold 1,954 Edwards Lifesciences shares in Q2 2026, an estimated $164K.
- Edwards Lifesciences made up 0.01% of KeyBank National Association's portfolio in Q2 2026, its #378 holding.
- KeyBank National Association first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 51 quarters since.
- KeyBank National Association's Edwards Lifesciences position peaked at $5.98M in Q4 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.